Therapy Areas: Inflammatory Diseases
18 September 2018 - Dermatology company Sebacia, Inc revealed on Monday that it has passed US Food and Drug Administration (FDA) clearance for its lead product, Sebacia Microparticles for the treatmen...
17 September 2018 - - US-based biopharmaceutical company Pfizer Inc. (NYSE: PFE) has released results from its Phase 2a study of PF-06651600, an oral Janus kinase 3 inhibitor, and PF-06700841, a tyros...
17 September 2018 - Pfizer Inc (NYSE:PFE) a US-based pharmaceutical company announced on Saturday results from its Phase 2a study of PF-06651600, an oral Janus kinase (JAK) 3 inhibitor, and PF-0670084...
14 September 2018 - - US-based drug and vaccine developer CEL-SCI Corp. (NYSE American: CVM)  has received USD 5,435,367 through the exercise of warrants to purchase shares of the company�...
14 September 2018 - - The US Food and Drug Administration has approved the subcutaneous formulation of Actemra (tocilizumab) for the treatment of active systemic juvenile idiopathic arthritis in ...
13 September 2018 - - The Janssen Pharmaceutical Companies of Johnson and Johnson (NYSEL JNJ) has released new data that show considerable improvements in long-term patient-reported outcomes in patien...
Related Headlines